0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hereditary Disease Carrier Screening Market Research Report 2026
Published Date: 2026-03-06
|
Report Code: QYRE-Auto-39D20133
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Hereditary Disease Carrier Screening Market Research Report 2026
BUY CHAPTERS

Global Hereditary Disease Carrier Screening Market Research Report 2026

Code: QYRE-Auto-39D20133
Report
2026-03-06
Pages:166
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hereditary Disease Carrier Screening Market Size

The global Hereditary Disease Carrier Screening market was valued at US$ 2614 million in 2025 and is anticipated to reach US$ 4814 million by 2032, at a CAGR of 9.2% from 2026 to 2032.

Hereditary Disease Carrier Screening Market

Hereditary Disease Carrier Screening Market

Hereditary Disease Carrier Screening is genetic testing used to identify whether an individual carries gene changes associated with inherited disorders that could be passed to a child. It is commonly offered before or during pregnancy to assess reproductive risk, especially for conditions that are inherited in an autosomal recessive or X linked manner. The results help guide next steps such as partner testing and genetic counseling so that individuals and couples can make informed reproductive decisions, while recognizing that a negative result reduces but does not eliminate risk because screening cannot detect every possible disease or genetic variant.
The North American market for Hereditary Disease Carrier Screening is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Hereditary Disease Carrier Screening is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Hereditary Disease Carrier Screening in Couple is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Hereditary Disease Carrier Screening include Thermo Fisher Scientific, Eurofins Scientific, Illumina, Labcorp, Quest Diagnostics, MedGenome, Myriad Genetics, Natera, OPKO Health, 23andMe, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Hereditary Disease Carrier Screening market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hereditary Disease Carrier Screening. The Hereditary Disease Carrier Screening market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Hereditary Disease Carrier Screening market comprehensively. Regional market sizes by Type, by Application, by Screening Timing, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hereditary Disease Carrier Screening manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Hereditary Disease Carrier Screening Market Report

Report Metric Details
Report Name Hereditary Disease Carrier Screening Market
Accounted market size in 2025 US$ 2614 million
Forecasted market size in 2032 US$ 4814 million
CAGR 9.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • NGS
  • Whole Exome Sequencing
  • Others
Segment by Screening Timing
  • Preconception Screening
  • Prenatal Screening
Segment by Screening Scope
  • Single-condition Screening
  • Targeted multi-condition Screening
Segment by Application
  • Couple
  • Individual
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Eurofins Scientific, Illumina, Labcorp, Quest Diagnostics, MedGenome, Myriad Genetics, Natera, OPKO Health, 23andMe, Mayo Clinic Laboratories, Baylor Genetics, GeneDx, Fulgent Genetics, NxGen MDx, Sonic Genetics, Ambry Genetics, PreventionGenetics, DiaSorin, SYNLAB, BGI Genomics, Berry Genomics, Annaroad, Jiajian Medical Testing, Genesky, Weihansi Biomedical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Screening Timing, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Hereditary Disease Carrier Screening companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Hereditary Disease Carrier Screening Market growing?

Ans: The Hereditary Disease Carrier Screening Market witnessing a CAGR of 9.2% during the forecast period 2026-2032.

What is the Hereditary Disease Carrier Screening Market size in 2032?

Ans: The Hereditary Disease Carrier Screening Market size in 2032 will be US$ 4814 million.

Who are the main players in the Hereditary Disease Carrier Screening Market report?

Ans: The main players in the Hereditary Disease Carrier Screening Market are Thermo Fisher Scientific, Eurofins Scientific, Illumina, Labcorp, Quest Diagnostics, MedGenome, Myriad Genetics, Natera, OPKO Health, 23andMe, Mayo Clinic Laboratories, Baylor Genetics, GeneDx, Fulgent Genetics, NxGen MDx, Sonic Genetics, Ambry Genetics, PreventionGenetics, DiaSorin, SYNLAB, BGI Genomics, Berry Genomics, Annaroad, Jiajian Medical Testing, Genesky, Weihansi Biomedical Technology

What are the Application segmentation covered in the Hereditary Disease Carrier Screening Market report?

Ans: The Applications covered in the Hereditary Disease Carrier Screening Market report are Couple, Individual

What are the Type segmentation covered in the Hereditary Disease Carrier Screening Market report?

Ans: The Types covered in the Hereditary Disease Carrier Screening Market report are NGS, Whole Exome Sequencing, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hereditary Disease Carrier Screening Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 NGS
1.2.3 Whole Exome Sequencing
1.2.4 Others
1.3 Market by Screening Timing
1.3.1 Global Hereditary Disease Carrier Screening Market Size Growth Rate by Screening Timing: 2021 vs 2025 vs 2032
1.3.2 Preconception Screening
1.3.3 Prenatal Screening
1.4 Market by Screening Scope
1.4.1 Global Hereditary Disease Carrier Screening Market Size Growth Rate by Screening Scope: 2021 vs 2025 vs 2032
1.4.2 Single-condition Screening
1.4.3 Targeted multi-condition Screening
1.5 Market by Application
1.5.1 Global Hereditary Disease Carrier Screening Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Couple
1.5.3 Individual
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Hereditary Disease Carrier Screening Market Perspective (2021–2032)
2.2 Global Hereditary Disease Carrier Screening Growth Trends by Region
2.2.1 Global Hereditary Disease Carrier Screening Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Hereditary Disease Carrier Screening Historic Market Size by Region (2021–2026)
2.2.3 Hereditary Disease Carrier Screening Forecasted Market Size by Region (2027–2032)
2.3 Hereditary Disease Carrier Screening Market Dynamics
2.3.1 Hereditary Disease Carrier Screening Industry Trends
2.3.2 Hereditary Disease Carrier Screening Market Drivers
2.3.3 Hereditary Disease Carrier Screening Market Challenges
2.3.4 Hereditary Disease Carrier Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hereditary Disease Carrier Screening Players by Revenue
3.1.1 Global Top Hereditary Disease Carrier Screening Players by Revenue (2021–2026)
3.1.2 Global Hereditary Disease Carrier Screening Revenue Market Share by Players (2021–2026)
3.2 Global Top Hereditary Disease Carrier Screening Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Hereditary Disease Carrier Screening Revenue
3.4 Global Hereditary Disease Carrier Screening Market Concentration Ratio
3.4.1 Global Hereditary Disease Carrier Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hereditary Disease Carrier Screening Revenue in 2025
3.5 Global Key Players of Hereditary Disease Carrier Screening Head Offices and Areas Served
3.6 Global Key Players of Hereditary Disease Carrier Screening, Products and Applications
3.7 Global Key Players of Hereditary Disease Carrier Screening, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Hereditary Disease Carrier Screening Breakdown Data by Type
4.1 Global Hereditary Disease Carrier Screening Historic Market Size by Type (2021–2026)
4.2 Global Hereditary Disease Carrier Screening Forecasted Market Size by Type (2027–2032)
5 Hereditary Disease Carrier Screening Breakdown Data by Application
5.1 Global Hereditary Disease Carrier Screening Historic Market Size by Application (2021–2026)
5.2 Global Hereditary Disease Carrier Screening Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Hereditary Disease Carrier Screening Market Size (2021–2032)
6.2 North America Hereditary Disease Carrier Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Hereditary Disease Carrier Screening Market Size by Country (2021–2026)
6.4 North America Hereditary Disease Carrier Screening Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hereditary Disease Carrier Screening Market Size (2021–2032)
7.2 Europe Hereditary Disease Carrier Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Hereditary Disease Carrier Screening Market Size by Country (2021–2026)
7.4 Europe Hereditary Disease Carrier Screening Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Hereditary Disease Carrier Screening Market Size (2021–2032)
8.2 Asia-Pacific Hereditary Disease Carrier Screening Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Hereditary Disease Carrier Screening Market Size by Region (2021–2026)
8.4 Asia-Pacific Hereditary Disease Carrier Screening Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Hereditary Disease Carrier Screening Market Size (2021–2032)
9.2 Latin America Hereditary Disease Carrier Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Hereditary Disease Carrier Screening Market Size by Country (2021–2026)
9.4 Latin America Hereditary Disease Carrier Screening Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hereditary Disease Carrier Screening Market Size (2021–2032)
10.2 Middle East & Africa Hereditary Disease Carrier Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Hereditary Disease Carrier Screening Market Size by Country (2021–2026)
10.4 Middle East & Africa Hereditary Disease Carrier Screening Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Hereditary Disease Carrier Screening Introduction
11.1.4 Thermo Fisher Scientific Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Hereditary Disease Carrier Screening Introduction
11.2.4 Eurofins Scientific Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.2.5 Eurofins Scientific Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Hereditary Disease Carrier Screening Introduction
11.3.4 Illumina Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.3.5 Illumina Recent Development
11.4 Labcorp
11.4.1 Labcorp Company Details
11.4.2 Labcorp Business Overview
11.4.3 Labcorp Hereditary Disease Carrier Screening Introduction
11.4.4 Labcorp Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.4.5 Labcorp Recent Development
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Company Details
11.5.2 Quest Diagnostics Business Overview
11.5.3 Quest Diagnostics Hereditary Disease Carrier Screening Introduction
11.5.4 Quest Diagnostics Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.5.5 Quest Diagnostics Recent Development
11.6 MedGenome
11.6.1 MedGenome Company Details
11.6.2 MedGenome Business Overview
11.6.3 MedGenome Hereditary Disease Carrier Screening Introduction
11.6.4 MedGenome Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.6.5 MedGenome Recent Development
11.7 Myriad Genetics
11.7.1 Myriad Genetics Company Details
11.7.2 Myriad Genetics Business Overview
11.7.3 Myriad Genetics Hereditary Disease Carrier Screening Introduction
11.7.4 Myriad Genetics Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.7.5 Myriad Genetics Recent Development
11.8 Natera
11.8.1 Natera Company Details
11.8.2 Natera Business Overview
11.8.3 Natera Hereditary Disease Carrier Screening Introduction
11.8.4 Natera Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.8.5 Natera Recent Development
11.9 OPKO Health
11.9.1 OPKO Health Company Details
11.9.2 OPKO Health Business Overview
11.9.3 OPKO Health Hereditary Disease Carrier Screening Introduction
11.9.4 OPKO Health Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.9.5 OPKO Health Recent Development
11.10 23andMe
11.10.1 23andMe Company Details
11.10.2 23andMe Business Overview
11.10.3 23andMe Hereditary Disease Carrier Screening Introduction
11.10.4 23andMe Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.10.5 23andMe Recent Development
11.11 Mayo Clinic Laboratories
11.11.1 Mayo Clinic Laboratories Company Details
11.11.2 Mayo Clinic Laboratories Business Overview
11.11.3 Mayo Clinic Laboratories Hereditary Disease Carrier Screening Introduction
11.11.4 Mayo Clinic Laboratories Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.11.5 Mayo Clinic Laboratories Recent Development
11.12 Baylor Genetics
11.12.1 Baylor Genetics Company Details
11.12.2 Baylor Genetics Business Overview
11.12.3 Baylor Genetics Hereditary Disease Carrier Screening Introduction
11.12.4 Baylor Genetics Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.12.5 Baylor Genetics Recent Development
11.13 GeneDx
11.13.1 GeneDx Company Details
11.13.2 GeneDx Business Overview
11.13.3 GeneDx Hereditary Disease Carrier Screening Introduction
11.13.4 GeneDx Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.13.5 GeneDx Recent Development
11.14 Fulgent Genetics
11.14.1 Fulgent Genetics Company Details
11.14.2 Fulgent Genetics Business Overview
11.14.3 Fulgent Genetics Hereditary Disease Carrier Screening Introduction
11.14.4 Fulgent Genetics Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.14.5 Fulgent Genetics Recent Development
11.15 NxGen MDx
11.15.1 NxGen MDx Company Details
11.15.2 NxGen MDx Business Overview
11.15.3 NxGen MDx Hereditary Disease Carrier Screening Introduction
11.15.4 NxGen MDx Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.15.5 NxGen MDx Recent Development
11.16 Sonic Genetics
11.16.1 Sonic Genetics Company Details
11.16.2 Sonic Genetics Business Overview
11.16.3 Sonic Genetics Hereditary Disease Carrier Screening Introduction
11.16.4 Sonic Genetics Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.16.5 Sonic Genetics Recent Development
11.17 Ambry Genetics
11.17.1 Ambry Genetics Company Details
11.17.2 Ambry Genetics Business Overview
11.17.3 Ambry Genetics Hereditary Disease Carrier Screening Introduction
11.17.4 Ambry Genetics Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.17.5 Ambry Genetics Recent Development
11.18 PreventionGenetics
11.18.1 PreventionGenetics Company Details
11.18.2 PreventionGenetics Business Overview
11.18.3 PreventionGenetics Hereditary Disease Carrier Screening Introduction
11.18.4 PreventionGenetics Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.18.5 PreventionGenetics Recent Development
11.19 DiaSorin
11.19.1 DiaSorin Company Details
11.19.2 DiaSorin Business Overview
11.19.3 DiaSorin Hereditary Disease Carrier Screening Introduction
11.19.4 DiaSorin Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.19.5 DiaSorin Recent Development
11.20 SYNLAB
11.20.1 SYNLAB Company Details
11.20.2 SYNLAB Business Overview
11.20.3 SYNLAB Hereditary Disease Carrier Screening Introduction
11.20.4 SYNLAB Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.20.5 SYNLAB Recent Development
11.21 BGI Genomics
11.21.1 BGI Genomics Company Details
11.21.2 BGI Genomics Business Overview
11.21.3 BGI Genomics Hereditary Disease Carrier Screening Introduction
11.21.4 BGI Genomics Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.21.5 BGI Genomics Recent Development
11.22 Berry Genomics
11.22.1 Berry Genomics Company Details
11.22.2 Berry Genomics Business Overview
11.22.3 Berry Genomics Hereditary Disease Carrier Screening Introduction
11.22.4 Berry Genomics Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.22.5 Berry Genomics Recent Development
11.23 Annaroad
11.23.1 Annaroad Company Details
11.23.2 Annaroad Business Overview
11.23.3 Annaroad Hereditary Disease Carrier Screening Introduction
11.23.4 Annaroad Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.23.5 Annaroad Recent Development
11.24 Jiajian Medical Testing
11.24.1 Jiajian Medical Testing Company Details
11.24.2 Jiajian Medical Testing Business Overview
11.24.3 Jiajian Medical Testing Hereditary Disease Carrier Screening Introduction
11.24.4 Jiajian Medical Testing Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.24.5 Jiajian Medical Testing Recent Development
11.25 Genesky
11.25.1 Genesky Company Details
11.25.2 Genesky Business Overview
11.25.3 Genesky Hereditary Disease Carrier Screening Introduction
11.25.4 Genesky Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.25.5 Genesky Recent Development
11.26 Weihansi Biomedical Technology
11.26.1 Weihansi Biomedical Technology Company Details
11.26.2 Weihansi Biomedical Technology Business Overview
11.26.3 Weihansi Biomedical Technology Hereditary Disease Carrier Screening Introduction
11.26.4 Weihansi Biomedical Technology Revenue in Hereditary Disease Carrier Screening Business (2021–2026)
11.26.5 Weihansi Biomedical Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Hereditary Disease Carrier Screening Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of NGS
 Table 3. Key Players of Whole Exome Sequencing
 Table 4. Key Players of Others
 Table 5. Global Hereditary Disease Carrier Screening Market Size Growth Rate by Screening Timing (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Key Players of Preconception Screening
 Table 7. Key Players of Prenatal Screening
 Table 8. Global Hereditary Disease Carrier Screening Market Size Growth Rate by Screening Scope (US$ Million): 2021 vs 2025 vs 2032
 Table 9. Key Players of Single-condition Screening
 Table 10. Key Players of Targeted multi-condition Screening
 Table 11. Global Hereditary Disease Carrier Screening Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 12. Global Hereditary Disease Carrier Screening Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 13. Global Hereditary Disease Carrier Screening Market Size by Region (US$ Million), 2021–2026
 Table 14. Global Hereditary Disease Carrier Screening Market Share by Region (2021–2026)
 Table 15. Global Hereditary Disease Carrier Screening Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 16. Global Hereditary Disease Carrier Screening Market Share by Region (2027–2032)
 Table 17. Hereditary Disease Carrier Screening Market Trends
 Table 18. Hereditary Disease Carrier Screening Market Drivers
 Table 19. Hereditary Disease Carrier Screening Market Challenges
 Table 20. Hereditary Disease Carrier Screening Market Restraints
 Table 21. Global Hereditary Disease Carrier Screening Revenue by Players (US$ Million), 2021–2026
 Table 22. Global Hereditary Disease Carrier Screening Market Share by Players (2021–2026)
 Table 23. Global Top Hereditary Disease Carrier Screening Players by Tier (Tier 1, Tier 2, and Tier 3), based on Hereditary Disease Carrier Screening Revenue, 2025
 Table 24. Ranking of Global Top Hereditary Disease Carrier Screening Companies by Revenue (US$ Million) in 2025
 Table 25. Global 5 Largest Players Market Share by Hereditary Disease Carrier Screening Revenue (CR5 and HHI), 2021–2026
 Table 26. Global Key Players of Hereditary Disease Carrier Screening, Headquarters and Area Served
 Table 27. Global Key Players of Hereditary Disease Carrier Screening, Products and Applications
 Table 28. Global Key Players of Hereditary Disease Carrier Screening, Date of General Availability (GA)
 Table 29. Mergers and Acquisitions, Expansion Plans
 Table 30. Global Hereditary Disease Carrier Screening Market Size by Type (US$ Million), 2021–2026
 Table 31. Global Hereditary Disease Carrier Screening Revenue Market Share by Type (2021–2026)
 Table 32. Global Hereditary Disease Carrier Screening Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 33. Global Hereditary Disease Carrier Screening Revenue Market Share by Type (2027–2032)
 Table 34. Global Hereditary Disease Carrier Screening Market Size by Application (US$ Million), 2021–2026
 Table 35. Global Hereditary Disease Carrier Screening Revenue Market Share by Application (2021–2026)
 Table 36. Global Hereditary Disease Carrier Screening Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 37. Global Hereditary Disease Carrier Screening Revenue Market Share by Application (2027–2032)
 Table 38. North America Hereditary Disease Carrier Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 39. North America Hereditary Disease Carrier Screening Market Size by Country (US$ Million), 2021–2026
 Table 40. North America Hereditary Disease Carrier Screening Market Size by Country (US$ Million), 2027–2032
 Table 41. Europe Hereditary Disease Carrier Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Europe Hereditary Disease Carrier Screening Market Size by Country (US$ Million), 2021–2026
 Table 43. Europe Hereditary Disease Carrier Screening Market Size by Country (US$ Million), 2027–2032
 Table 44. Asia-Pacific Hereditary Disease Carrier Screening Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Asia-Pacific Hereditary Disease Carrier Screening Market Size by Region (US$ Million), 2021–2026
 Table 46. Asia-Pacific Hereditary Disease Carrier Screening Market Size by Region (US$ Million), 2027–2032
 Table 47. Latin America Hereditary Disease Carrier Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 48. Latin America Hereditary Disease Carrier Screening Market Size by Country (US$ Million), 2021–2026
 Table 49. Latin America Hereditary Disease Carrier Screening Market Size by Country (US$ Million), 2027–2032
 Table 50. Middle East & Africa Hereditary Disease Carrier Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 51. Middle East & Africa Hereditary Disease Carrier Screening Market Size by Country (US$ Million), 2021–2026
 Table 52. Middle East & Africa Hereditary Disease Carrier Screening Market Size by Country (US$ Million), 2027–2032
 Table 53. Thermo Fisher Scientific Company Details
 Table 54. Thermo Fisher Scientific Business Overview
 Table 55. Thermo Fisher Scientific Hereditary Disease Carrier Screening Product
 Table 56. Thermo Fisher Scientific Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 57. Thermo Fisher Scientific Recent Development
 Table 58. Eurofins Scientific Company Details
 Table 59. Eurofins Scientific Business Overview
 Table 60. Eurofins Scientific Hereditary Disease Carrier Screening Product
 Table 61. Eurofins Scientific Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 62. Eurofins Scientific Recent Development
 Table 63. Illumina Company Details
 Table 64. Illumina Business Overview
 Table 65. Illumina Hereditary Disease Carrier Screening Product
 Table 66. Illumina Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 67. Illumina Recent Development
 Table 68. Labcorp Company Details
 Table 69. Labcorp Business Overview
 Table 70. Labcorp Hereditary Disease Carrier Screening Product
 Table 71. Labcorp Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 72. Labcorp Recent Development
 Table 73. Quest Diagnostics Company Details
 Table 74. Quest Diagnostics Business Overview
 Table 75. Quest Diagnostics Hereditary Disease Carrier Screening Product
 Table 76. Quest Diagnostics Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 77. Quest Diagnostics Recent Development
 Table 78. MedGenome Company Details
 Table 79. MedGenome Business Overview
 Table 80. MedGenome Hereditary Disease Carrier Screening Product
 Table 81. MedGenome Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 82. MedGenome Recent Development
 Table 83. Myriad Genetics Company Details
 Table 84. Myriad Genetics Business Overview
 Table 85. Myriad Genetics Hereditary Disease Carrier Screening Product
 Table 86. Myriad Genetics Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 87. Myriad Genetics Recent Development
 Table 88. Natera Company Details
 Table 89. Natera Business Overview
 Table 90. Natera Hereditary Disease Carrier Screening Product
 Table 91. Natera Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 92. Natera Recent Development
 Table 93. OPKO Health Company Details
 Table 94. OPKO Health Business Overview
 Table 95. OPKO Health Hereditary Disease Carrier Screening Product
 Table 96. OPKO Health Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 97. OPKO Health Recent Development
 Table 98. 23andMe Company Details
 Table 99. 23andMe Business Overview
 Table 100. 23andMe Hereditary Disease Carrier Screening Product
 Table 101. 23andMe Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 102. 23andMe Recent Development
 Table 103. Mayo Clinic Laboratories Company Details
 Table 104. Mayo Clinic Laboratories Business Overview
 Table 105. Mayo Clinic Laboratories Hereditary Disease Carrier Screening Product
 Table 106. Mayo Clinic Laboratories Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 107. Mayo Clinic Laboratories Recent Development
 Table 108. Baylor Genetics Company Details
 Table 109. Baylor Genetics Business Overview
 Table 110. Baylor Genetics Hereditary Disease Carrier Screening Product
 Table 111. Baylor Genetics Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 112. Baylor Genetics Recent Development
 Table 113. GeneDx Company Details
 Table 114. GeneDx Business Overview
 Table 115. GeneDx Hereditary Disease Carrier Screening Product
 Table 116. GeneDx Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 117. GeneDx Recent Development
 Table 118. Fulgent Genetics Company Details
 Table 119. Fulgent Genetics Business Overview
 Table 120. Fulgent Genetics Hereditary Disease Carrier Screening Product
 Table 121. Fulgent Genetics Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 122. Fulgent Genetics Recent Development
 Table 123. NxGen MDx Company Details
 Table 124. NxGen MDx Business Overview
 Table 125. NxGen MDx Hereditary Disease Carrier Screening Product
 Table 126. NxGen MDx Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 127. NxGen MDx Recent Development
 Table 128. Sonic Genetics Company Details
 Table 129. Sonic Genetics Business Overview
 Table 130. Sonic Genetics Hereditary Disease Carrier Screening Product
 Table 131. Sonic Genetics Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 132. Sonic Genetics Recent Development
 Table 133. Ambry Genetics Company Details
 Table 134. Ambry Genetics Business Overview
 Table 135. Ambry Genetics Hereditary Disease Carrier Screening Product
 Table 136. Ambry Genetics Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 137. Ambry Genetics Recent Development
 Table 138. PreventionGenetics Company Details
 Table 139. PreventionGenetics Business Overview
 Table 140. PreventionGenetics Hereditary Disease Carrier Screening Product
 Table 141. PreventionGenetics Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 142. PreventionGenetics Recent Development
 Table 143. DiaSorin Company Details
 Table 144. DiaSorin Business Overview
 Table 145. DiaSorin Hereditary Disease Carrier Screening Product
 Table 146. DiaSorin Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 147. DiaSorin Recent Development
 Table 148. SYNLAB Company Details
 Table 149. SYNLAB Business Overview
 Table 150. SYNLAB Hereditary Disease Carrier Screening Product
 Table 151. SYNLAB Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 152. SYNLAB Recent Development
 Table 153. BGI Genomics Company Details
 Table 154. BGI Genomics Business Overview
 Table 155. BGI Genomics Hereditary Disease Carrier Screening Product
 Table 156. BGI Genomics Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 157. BGI Genomics Recent Development
 Table 158. Berry Genomics Company Details
 Table 159. Berry Genomics Business Overview
 Table 160. Berry Genomics Hereditary Disease Carrier Screening Product
 Table 161. Berry Genomics Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 162. Berry Genomics Recent Development
 Table 163. Annaroad Company Details
 Table 164. Annaroad Business Overview
 Table 165. Annaroad Hereditary Disease Carrier Screening Product
 Table 166. Annaroad Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 167. Annaroad Recent Development
 Table 168. Jiajian Medical Testing Company Details
 Table 169. Jiajian Medical Testing Business Overview
 Table 170. Jiajian Medical Testing Hereditary Disease Carrier Screening Product
 Table 171. Jiajian Medical Testing Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 172. Jiajian Medical Testing Recent Development
 Table 173. Genesky Company Details
 Table 174. Genesky Business Overview
 Table 175. Genesky Hereditary Disease Carrier Screening Product
 Table 176. Genesky Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 177. Genesky Recent Development
 Table 178. Weihansi Biomedical Technology Company Details
 Table 179. Weihansi Biomedical Technology Business Overview
 Table 180. Weihansi Biomedical Technology Hereditary Disease Carrier Screening Product
 Table 181. Weihansi Biomedical Technology Revenue in Hereditary Disease Carrier Screening Business (US$ Million), 2021–2026
 Table 182. Weihansi Biomedical Technology Recent Development
 Table 183. Research Programs/Design for This Report
 Table 184. Key Data Information from Secondary Sources
 Table 185. Key Data Information from Primary Sources
 Table 186. Authors List of This Report


List of Figures
 Figure 1. Hereditary Disease Carrier Screening Picture
 Figure 2. Global Hereditary Disease Carrier Screening Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Hereditary Disease Carrier Screening Market Share by Type: 2025 vs 2032
 Figure 4. NGS Features
 Figure 5. Whole Exome Sequencing Features
 Figure 6. Others Features
 Figure 7. Global Hereditary Disease Carrier Screening Market Size Comparison by Screening Timing (US$ Million), 2021–2032
 Figure 8. Preconception Screening Features
 Figure 9. Prenatal Screening Features
 Figure 10. Global Hereditary Disease Carrier Screening Market Size Comparison by Screening Scope (US$ Million), 2021–2032
 Figure 11. Single-condition Screening Features
 Figure 12. Targeted multi-condition Screening Features
 Figure 13. Global Hereditary Disease Carrier Screening Market Size by Application (US$ Million), 2021–2032
 Figure 14. Global Hereditary Disease Carrier Screening Market Share by Application: 2025 vs 2032
 Figure 15. Couple Case Studies
 Figure 16. Individual Case Studies
 Figure 17. Hereditary Disease Carrier Screening Report Years Considered
 Figure 18. Global Hereditary Disease Carrier Screening Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 19. Global Hereditary Disease Carrier Screening Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 20. Global Hereditary Disease Carrier Screening Market Share by Region: 2025 vs 2032
 Figure 21. Global Hereditary Disease Carrier Screening Market Share by Players in 2025
 Figure 22. Global Hereditary Disease Carrier Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 23. The Top 10 and 5 Players Market Share by Hereditary Disease Carrier Screening Revenue in 2025
 Figure 24. North America Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. North America Hereditary Disease Carrier Screening Market Share by Country (2021–2032)
 Figure 26. United States Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Canada Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Europe Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Europe Hereditary Disease Carrier Screening Market Share by Country (2021–2032)
 Figure 30. Germany Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. France Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. U.K. Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Italy Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Russia Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Ireland Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Asia-Pacific Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Asia-Pacific Hereditary Disease Carrier Screening Market Share by Region (2021–2032)
 Figure 38. China Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Japan Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. South Korea Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Southeast Asia Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. India Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Australia & New Zealand Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Latin America Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Latin America Hereditary Disease Carrier Screening Market Share by Country (2021–2032)
 Figure 46. Mexico Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Brazil Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Middle East & Africa Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Middle East & Africa Hereditary Disease Carrier Screening Market Share by Country (2021–2032)
 Figure 50. Israel Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. UAE Hereditary Disease Carrier Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 54. Eurofins Scientific Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 55. Illumina Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 56. Labcorp Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 57. Quest Diagnostics Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 58. MedGenome Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 59. Myriad Genetics Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 60. Natera Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 61. OPKO Health Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 62. 23andMe Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 63. Mayo Clinic Laboratories Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 64. Baylor Genetics Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 65. GeneDx Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 66. Fulgent Genetics Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 67. NxGen MDx Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 68. Sonic Genetics Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 69. Ambry Genetics Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 70. PreventionGenetics Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 71. DiaSorin Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 72. SYNLAB Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 73. BGI Genomics Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 74. Berry Genomics Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 75. Annaroad Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 76. Jiajian Medical Testing Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 77. Genesky Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 78. Weihansi Biomedical Technology Revenue Growth Rate in Hereditary Disease Carrier Screening Business (2021–2026)
 Figure 79. Bottom-up and Top-down Approaches for This Report
 Figure 80. Data Triangulation
 Figure 81. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS